Home  >  News
Inovio begins phase 1/2a study of INO-5401 plus INO-9012 in combo with atezolizumab to treat advanced/metastatic bladder cancer  August 18, 2018
Ember Therapeutics to divest OP-1 Portfolio to Viscogliosi Brothers  August 18, 2018
Iovance announces clinical trial updates with collaborators MD Anderson & Moffitt Cancer Center  August 18, 2018
Shanghai ChemPartner closes merger deal with Quantum  August 18, 2018
Regeneron, Teva announce phase 3 study of fasinumab in patients with chronic pain from OA meets primary & secondary endpoints  August 18, 2018
US FDA approves kinase inhibitor Lenvima to treat patients with unresectable hepatocellular carcinoma  August 18, 2018
MyDentistChoice gets second round of funding for its global expansion  August 18, 2018
US FDA approves Teva Pharma's EpiPen auto-injector to treat allergic reactions  August 18, 2018
BioNTech inks pact with Pfizer to develop mRNA-based vaccines for prevention of influenza  August 18, 2018
Experts see ban on 343 FDC drugs to be a major blow to pharma sector  August 18, 2018
cphikorea_150x60_saffron media
Copyright © 2016 Saffron Media Pvt. Ltd |